Capital expenditure increased 48.9%
Capital expenditure changed +48.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +48.9% from the comparable as-filed period.
Free-cash-flow margin changed +623 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +1154 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash / debt changed +1074081875 basis points from the comparable as-filed period.
Operating income changed -5.5% from the comparable as-filed period.
Revenue changed +2.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -383 basis points from the comparable as-filed period.
Gross margin changed -47 basis points from the comparable as-filed period.
Cash & equivalents changed +14.6% from the comparable as-filed period.
Gross debt changed -75.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Reported total debt changed -75.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash flow / net income changed +20.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +22.4% from the comparable as-filed period.
Net debt changed -14.6% from the comparable as-filed period.
Current assets changed +11.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -13.2% from the comparable as-filed period.
Inventory / revenue changed -21 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Stock-based compensation changed +17.2% from the comparable as-filed period.
Working capital / assets changed -72 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Trade receivables changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed +22 basis points from the comparable as-filed period.
Gross profit changed +1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / revenue changed -1 basis points from the comparable as-filed period.
R&D / revenue changed -31 basis points from the comparable as-filed period.
Current ratio changed -0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / assets changed -0 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.